National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 61604 [2023-19260]
Download as PDF
<![CDATA[
61604
Federal Register / Vol. 88, No. 172 / Thursday, September 7, 2023 / Notices
REPORTING REQUIREMENTS—Continued
Number of
respondents
Total
annual
responses
Hours per
response
Total burden
hours
Student Financial Aid Transcript ..................................
Loan Information Disclosure .........................................
Entrance Interview ........................................................
Exit Interview ................................................................
Notification of Repayment ............................................
Notification During Deferment ......................................
Notification of Delinquent Accounts ..............................
Credit Bureau Notification .............................................
Write-off of Uncollectable Loans ..................................
Disability Cancellation ...................................................
Administrative Hearings record retention .....................
Administrative Hearings reporting requirements ..........
4,600
325
325
* 334
* 334
* 333
334
334
520
3
0
0
1
299.5
139.5
113.5
862.5
17
172.5
6
1
1
0
0
4,600
97,338
45,338
37,909
288,075
5,661
57,615
2,004
520
3
0
0
0.25
0.63
0.50
1.00
0.38
0.63
1.25
0.50
3.00
1.00
0.00
0.00
1,150
61,323
22,669
37,909
109,469
3,566
72,019
1,002
1,560
3
0
0
HPSL Subtotal .......................................................
NSL:
Student Financial Aid Transcript ..................................
Entrance Interview ........................................................
Exit Interview ................................................................
Notification of Repayment ............................................
Notification During Deferment ......................................
Notification of Delinquent Accounts ..............................
Credit Bureau Notification .............................................
Write-off of Uncollectable Loans ..................................
Disability Cancellation ...................................................
Administrative Hearings ................................................
........................
........................
........................
........................
310,670
4,100
282
348
348
348
348
348
23
16
0
1
17.5
9
9
1.5
42.5
709
1
1
0
4,100
4,935
3,132
3,132
522
14,790
246,732
23
16
0
0.25
0.42
0.42
0.27
0.29
0.04
0.06
3.00
1.00
0.00
1,025
2,073
1,315
846
151
592
1,480
69
16
0
NSL Subtotal .........................................................
........................
........................
........................
........................
7,567
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2023–19203 Filed 9–6–23; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
Responses
per
respondent
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
19:19 Sep 06, 2023
Jkt 259001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA–DK–22–028
Pilot and Feasibility R01s to Integrate Soc
and Med Care in Type 1 Diabetes.
Date: October 12, 2023.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Cheryl Nordstrom, Ph.D.,
MPH, Scientific Review Officer, NIDDK/
Scientific Review Branch, National Institutes
of Health, 6707 Democracy Blvd., Room
7013, Bethesda, MD 20892, 301–402–6711,
cheryl.nordstrom@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
PO 00000
Dated: August 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–19260 Filed 9–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Frm 00106
Fmt 4703
Sfmt 4703
E:\FR\FM\07SEN1.SGM
07SEN1
]]>Agencies
[Federal Register Volume 88, Number 172 (Thursday, September 7, 2023)]
[Notices]
[Page 61604]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-19260]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA-DK-22-028 Pilot and
Feasibility R01s to Integrate Soc and Med Care in Type 1 Diabetes.
Date: October 12, 2023.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, NIDDK, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review
Officer, NIDDK/Scientific Review Branch, National Institutes of
Health, 6707 Democracy Blvd., Room 7013, Bethesda, MD 20892, 301-
402-6711, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 31, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-19260 Filed 9-6-23; 8:45 am]
BILLING CODE 4140-01-P
